Mark Donaldson, BSP, RPH, PharmD, FASHP, FACHELecture
This course is offered in cooperation with the Oregon Health Sciences University Office of Continuing Dental Education.
Electronic nicotine delivery systems, electronic cigarettes (e-cigarettes), or vapes are a relatively new product category, which first emerged in 2004. E-cigarettes have been growing in use and are a source of great debate among public health advocates and in the media. Emerging evidence demonstrates that e-cigarettes may not be less harmful than conventional cigarettes and with the legalization of e-cigarettes containing nicotine, cannabidiol (CBD) and other oil-based liquids, there is increased access to e-cigarettes for new and current smokers. This has become a significant issue among young people in particular. In 2015 the E-cigarette giant, Juul, expanded into the United States, adding a new verb to our lexicon, “juuling.” Today, with the deregulation of cannabis in a majority of the United States, many smokers are also reaching for marijuana or THC (tetrahydrocannabinol) to be a part of their smoking regime. Is it true that where there is smoke there is fire?
There have been more than 2,807 reported cases of people suffering lung injuries after using electronic cigarettes or vaping products in the U.S., along with 61 official deaths. In October of 2019, the Centers for Disease Control and Prevention (CDC) gave vaping-related illness an official name: e-cigarette or vaping product use associated lung injury, aka EVALI. Given the potential oral health concerns around smoking nicotine, marijuana and now E-cigarettes and vaping, all oral healthcare practitioners need to know the pathophysiology, latest research, symptom recognition and what EVALI treatment currently looks like – especially since the average age of these patients is just 27 years old.
This interactive program looks at some of these most challenging patients, their most common negative sequelae due to drug use and the management of these patients with a particular focus on the dental realm. Case studies will augment the delivery of key points and a problem-based learning approach is encouraged so that each participant’s questions are addressed. Most importantly, you will learn directly applicable strategies to successfully identify these medically-complex patients beginning on Monday morning. After all, our goal is to make sure all dental appointments are not just successful and safe for your patient, but also for you and your staff.
As a result of attending this class, you will be able to:
- Recognize the challenges and trends linking nicotine smoking, electronic cigarettes and the deregulation of cannabinoids on oral health
- Describe the history of vaping related health concerns and EVALI
- Explain the role of vitamin E acetate in the EVALI outbreak
- Summarize CDC treatment recommendations for EVALI
- Learn to identify and be a better resource on vaping-related trends for your patients
Mark Donaldson received his baccalaureate degree from the University of British Columbia and his Doctorate in Clinical Pharmacy from the University of Washington. He completed a residency at Vancouver General Hospital, and has practiced as a clinical pharmacy specialist, clinical coordinator and director of pharmacy services at many healthcare organizations in both Canada and the United States. He is currently the Associate Principal of Clinical Pharmacy for Vizient’s Advisory Solutions, and lives in Whitefish, Montana.
Dr. Donaldson is a Clinical Professor in the Department of Pharmacy at the University of Montana in Missoula, and Clinical Associate Professor in the School of Dentistry at the Oregon Health & Sciences University in Portland, Oregon. He has a special interest in dental pharmacology and has lectured internationally to both dental and medical practitioners. He has spent the last 20 years focusing on dental pharmacology and dental therapeutics, and is a leader in the field.
Dr. Donaldson has published numerous peer-reviewed works and textbook chapters. He currently serves on the Editorial Board for the Journal Healthcare Executive and the Journal of the American Dental Association and is a reviewer for over ten other different journals. He is board certified in healthcare management and is the Past-President and current Regent of the American College of Healthcare Executives’ Montana Chapter. Dr. Donaldson was named as the 2014 recipient of the Bowl of Hygeia for the state of Montana and is the 2016 recipient of the Dr. Thaddeus V. Weclew Award. This award is conferred upon an individual who has made outstanding contributions to the medical, dental and pharmacy literature.
- Dr. Donaldson has no relevant financial relationships to disclose.
- The staff of the University of Washington and Oregon Health Sciences Offices of Continuing Dental Education have no relevant financial relationships to disclose.
Saturday, March 25, 2023
Zoom live webinar
The whole dental team.
Course: 9:00am – 11:00am
$69/Team members (dental hygienist, dental assistant, office staff)
$79/Current Dental Alumni Member
* This course is eligible for a 10% tuition discount if you are a current member of the UW Dental Alumni Association.
The University of Washington and Oregon Health Sciences University are ADA CERP Recognized Providers.
ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.
This continuing education activity has been planned and implemented in accordance with the standards of the ADA Continuing Education Recognition Program (ADA CERP) through joint efforts between the University of Washington and Oregon Health Sciences University.
The University of Washington and Oregon Health Sciences University are members of the Association for Continuing Dental Education.
University of Washington and Oregon Health Sciences University designate this activity for 2 continuing education credits.